Position
Chief Business Officer
Company
Cardurion Pharmaceuticals
BostonBiotechnologyData And AnalyticsHealth CareScience And EngineeringDescription
Cardurion Pharmaceuticals, Inc. announced the appointment of Charlotte (Charlie) Newman as Chief Business Officer. Ms Newman, a biopharmaceutical industry executive with over 25 years of experience, will be responsible for leading corporate development, business development, portfolio strategy, and new product planning at Cardurion.
Quick answer
Charlotte Newman Joins Cardurion as Chief Business Officer (January 8, 2025). Cardurion Pharmaceuticals is based in Boston, Massachusetts, United States.
- Who is the new Chief Business Officer at Cardurion Pharmaceuticals?
- Cardurion Pharmaceuticals named Charlotte (Charlie) Newman Chief Business Officer, announced January 8, 2025.
- What did Cardurion Pharmaceuticals announce on January 8, 2025?
- Cardurion Pharmaceuticals, Inc. announced the appointment of Charlotte (Charlie) Newman as Chief Business Officer. Ms Newman, a biopharmaceutical industry executive with over 25 years of experience, will be responsible for leading corporate development, business development, portfolio strategy, and new product planning at Cardurion.
- What does Cardurion Pharmaceuticals do?
- Cardurion Pharmaceuticals is a next generation cardiovascular company focused on the discovery and development of novel therapeutics for the treatment of heart failure and other cardiovascular diseases.
- Where is Cardurion Pharmaceuticals based?
- Cardurion Pharmaceuticals is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Envisagenics (February 13, 2025), Septerna (January 6, 2025), Emmes (January 16, 2025) and Kyverna Therapeutics (January 21, 2025) also announced leadership changes within 45 days of Cardurion Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Data And Analytics and Science And Engineering
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Envisagenics Appoints Sudhir Rao, M.S., MBA as Chief Business Officer to Strengthen Leadership Team (February 13, 2025)
- Septerna Appoints Gil Labrucherie as Chief Financial Officer (January 6, 2025)
- Emmes Group Appoints Germaine Gross as Chief Commercial Officer of Emmes Biopharma (January 16, 2025)
- Kyverna Appoints Dr. Naji Gehchan as Chief Medical and Development Officer (January 21, 2025)
- TriSalus Appoints James (Jim) Young as Chief Financial Officer and Announces Promotions for Dr. Richard B. Marshak and Jodi Devlin (January 8, 2025)
- Quest Diagnostics Appoints Adrienne L. Brott as Senior VP and Chief Quality and Regulatory Affairs Officer (January 8, 2025)
Who to call at Cardurion Pharmaceuticals, and when
A new leader at Cardurion Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Cardurion Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cardurion Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cardurion Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cardurion Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cardurion Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.